| (Values in U.S. Thousands) | Sep, 2025 | Jun, 2025 | Mar, 2025 | Sep, 2024 | Jun, 2024 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | +100.00% |
| Net Income | -950 | -60 | -140 | -90 | -40 |
| Net Income Growth | -1,483.36% | +57.14% | -55.56% | -125.01% | +100.00% |
Curanex Pharmaceuticals Inc (CURX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Curanex Pharmaceuticals Inc. is a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases. Its lead candidate includes Phyto-N. Curanex Pharmaceuticals Inc. is headquartered in Jericho, New York.
Fiscal Year End Date: 12/31